对于病人来说，疾病还没有得到良好的控制，目前正在进行有关第三种药物即静脉前列腺素类依前列醇的研究。
For patients whose disease is still not well-controlled, studies are underway investigating the addition of a third agent, the intravenous prostanoid epoprostenol.
目的探讨米索前列醇（以下简称米索）配伍依沙吖啶终止16~18周妊娠的效果。
Objective To study the clinical effect of Misoprostol combined with rivanol to stop pregnancy during 16~18weeks.
目的探讨米索前列醇（以下简称米索）配伍依沙吖啶终止16~18周妊娠的效果。
Objective To study the clinical effect of Misoprostol combined with rivanol to stop pregnancy during 16~18weeks.
应用推荐